Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Tuesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

NYSE:AMPE opened at $0.10 on Tuesday. The company has a market cap of $114,000.00, a price-to-earnings ratio of -0.01 and a beta of 2.21. Ampio Pharmaceuticals has a fifty-two week low of $0.09 and a fifty-two week high of $8.30. The stock has a fifty day moving average price of $0.21 and a 200-day moving average price of $1.09.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.